Product NDC: | 0409-1029 |
Proprietary Name: | Voluven |
Non Proprietary Name: | HYDROXYETHYL STARCH 130/0.4 |
Active Ingredient(s): | 6 g/100mL & nbsp; HYDROXYETHYL STARCH 130/0.4 |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-1029 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BN070012 |
Marketing Category: | NDA |
Start Marketing Date: | 20100625 |
Package NDC: | 0409-1029-01 |
Package Description: | 20 BAG in 1 CARTON (0409-1029-01) > 500 mL in 1 BAG |
NDC Code | 0409-1029-01 |
Proprietary Name | Voluven |
Package Description | 20 BAG in 1 CARTON (0409-1029-01) > 500 mL in 1 BAG |
Product NDC | 0409-1029 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | HYDROXYETHYL STARCH 130/0.4 |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20100625 |
Marketing Category Name | NDA |
Labeler Name | Hospira, Inc. |
Substance Name | HYDROXYETHYL STARCH 130/0.4 |
Strength Number | 6 |
Strength Unit | g/100mL |
Pharmaceutical Classes | Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA],Starch [Chemical/Ingredient] |